1. A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium. Issue 11 (25th July 2013) Authors: Zorzi, Alexandra P.; Bernstein, Mark; Samson, Yvan; Wall, Donna A.; Desai, Sunil; Nicksy, Darcy; Wainman, Nancy; Eisenhauer, Elizabeth; Baruchel, Sylvain Journal: Pediatric blood & cancer Issue: Volume 60:Issue 11(2013:Nov.) Page Start: 1868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors. Issue 1 (17th August 2013) Authors: Morgenstern, Daniel A.; Marzouki, Monia; Bartels, Ute; Irwin, Meredith S.; Sholler, Giselle L.S.; Gammon, Janet; Yankanah, Rosanna; Wu, Bing; Samson, Yvan; Baruchel, Sylvain Journal: Pediatric blood & cancer Issue: Volume 61:Issue 1(2014:Jan.) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗